Peripheral Drug Eluting Balloons Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region

Description

The global peripheral drug eluting balloons (DEBs) market has witnessed significant growth over the past decade, reaching a market value of US$ 950 million in 2024. The market is poised for continued expansion, with an anticipated 9.56% CAGR, expected to reach a valuation of US$ 1800 million by the end of 2031.

The Growing Challenge of Peripheral Vascular Disease

Peripheral vascular disease, characterized by the narrowing or obstruction of blood arteries that supply the limbs, is a global health concern primarily caused by the accumulation of fatty plaques in arteries. The market for peripheral drug eluting balloons is expanding due to the increasing incidence of peripheral arterial disease (PAD) worldwide.

According to the National Institutes of Health, in 2020, lifestyle changes, smoking, pollution, and other factors contributed to the condition claiming the lives of 20% of individuals aged 55 and older.

The prevalence of PAD and the need for interventional cardiology care are on the rise, making angioplasty, often performed using DEBs, the preferred treatment for long-term PAD.

The Centers for Disease Control and Prevention (CDC) reported in 2021 that approximately 8.5 million people in the U.S. had PAD, with 12% to 20% of individuals over 60 years of age affected.

Driving Forces Behind the Rapid Adoption of Peripheral Drug Eluting Balloons

Rising Aging Population and Increasing Vascular Diseases: The elderly population is more susceptible to vascular diseases due to natural aging processes, contributing to the growing demand for peripheral vascular surgeries. The increased use of stents during surgeries among the elderly, coupled with improved life expectancies, has created significant opportunities for manufacturers.

According to the United Nations, middle-income countries are expected to experience rapid growth in the number of older individuals between 2015 and 2030, with projections indicating a 64% increase in India and a 71% increase in China.

The U.S. is also experiencing substantial demographic changes, with the population of Americans aged 65 and older expected to more than double from 46 million to over 98 million by 2060, according to the Population Reference Bureau in 2023.

Challenges Faced by Market Players

High Product Cost and Limited Clinical Evidence: The cost of peripheral DEBs, including the device and drug, can be relatively high compared to traditional treatment options such as angioplasty or stenting. Higher upfront costs may deter adoption, especially in regions with limited healthcare budgets or reimbursement constraints. The cost factor remains a significant consideration for healthcare providers and payers when evaluating DEBs against alternative treatments.

Although DEBs have demonstrated promising clinical results, the market requires robust long-term clinical evidence and large-scale randomized controlled trials to establish their efficacy and superiority over alternative treatments. The limited availability of long-term data on patient outcomes can impact the confidence of healthcare providers in adopting DEBs as the standard treatment option.

Country-wise Insights

United States: A Prominent Market for Peripheral Drug Eluting Balloons

The U.S. peripheral DEBs market is poised for substantial growth due to advanced product development and the increasing prevalence of peripheral artery diseases in the country. The rising prevalence is driven by factors such as an aging population, high rates of diabetes, obesity, and lifestyle-related risks like smoking.

The U.S. Department of Health & Human Services reported in 2023 that approximately 6.5 million people aged 40 and older in the U.S. are living with PAD.

China: A Lucrative Market for Peripheral Drug Eluting Balloon Manufacturers

China offers a promising market for DEB manufacturers, supported by favorable government policies and reimbursement support. The Chinese government's healthcare reforms and investments aim to improve healthcare access, enhance reimbursement schemes, and reduce patient financial burdens. Favorable reimbursement policies have incentivized healthcare providers to adopt DEBs on a larger scale.

Chinese medical device manufacturers have engaged in collaborations with international companies to access advanced technologies and expertise, facilitating the introduction of advanced DEB products to the Chinese market.

Germany: Growing Demand for Peripheral Drug Eluting Balloons

Germany's advanced healthcare infrastructure, equipped with well-established hospitals, specialized medical centers, and skilled healthcare professionals, fosters an environment conducive to the adoption of innovative medical technologies like DEBs. Increasing awareness and education about peripheral artery disease and available treatment options have contributed to greater acceptance and adoption of DEBs in Germany.

Key Companies in the Market

Abbott Laboratories
Boston Scientific Corporation
Cook Medical Inc.
MicroPort Scientific Corporation (Endovastec™)
Medtronic Plc.
Cardinal Health, Inc.
B. Braun Melsungen AG
BIOTRONIK SE & Co. KG
Becton, Dickinson and Company
W. L. Gore & Associates Inc.
Getinge AB
Terumo Corp
Kyoto Medical Planning Co Ltd
iVascular S.L.U
AMG International GmbH
ENDOCOR GmbH
Meril Life Sciences Pvt. Ltd.
Nano Therapeutics Pvt Ltd
Koninklijke Philips N.V.
REVA Medical

Key Segments of Peripheral Drug Eluting Balloons Industry Research

Drug Coating:

Paclitaxel Drug Coating
Sirolimus drug Coating
Others

Indication:

Peripheral Arterial Disease
Peripheral Aneurysms
In-Stent Restenosis
Others

Artery Type:

Carotid Arteries
Fem-Pop Arteries
Iliac Arteries
Infrapop Arteries

End User:

Hospitals
Ambulatory Surgical Centers/Outpatients
Cardiac Catheterization Labs

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

1. Executive Summary

1.1. Global Peripheral Drug Eluting Balloons Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Peripheral Drug Eluting Balloons Market Outlook, 2018 - 2031

3.1. Global Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Paclitaxel Drug Coating
  - 3.1.1.2. Sirolimus Drug Coating
  - 3.1.1.3. Others
3.2. Global Peripheral Drug Eluting Balloons Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Peripheral Arterial Disease
  - 3.2.1.2. Peripheral Aneurysms
  - 3.2.1.3. In Stent Restenosis
  - 3.2.1.4. Others
3.3. Global Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Carotid Arteries
  - 3.3.1.2. Fem-Pop Arteries
  - 3.3.1.3. Illiac Arteries
  - 3.3.1.4. Infrapop Arteries
3.4. Global Peripheral Drug Eluting Balloons Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. Hospitals
  - 3.4.1.2. Ambulatory Surgical Centers / Outpatients
  - 3.4.1.3. Cardiac Catheterization Labs
3.5. Global Peripheral Drug Eluting Balloons Market Outlook, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 3.5.1. Key Highlights
  - 3.5.1.1. North America
  - 3.5.1.2. Europe
  - 3.5.1.3. Asia Pacific
  - 3.5.1.4. Latin America
  - 3.5.1.5. Middle East & Africa

4. North America Peripheral Drug Eluting Balloons Market Outlook, 2018 - 2031

4.1. North America Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Paclitaxel Drug Coating
  - 4.1.1.2. Sirolimus Drug Coating
  - 4.1.1.3. Others
4.2. North America Peripheral Drug Eluting Balloons Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Peripheral Arterial Disease
  - 4.2.1.2. Peripheral Aneurysms
  - 4.2.1.3. In Stent Restenosis
  - 4.2.1.4. Others
4.3. North America Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Carotid Arteries
  - 4.3.1.2. Fem-Pop Arteries
  - 4.3.1.3. Illiac Arteries
  - 4.3.1.4. Infrapop Arteries
4.4. North America Peripheral Drug Eluting Balloons Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. Hospitals
  - 4.4.1.2. Ambulatory Surgical Centers / Outpatients
  - 4.4.1.3. Cardiac Catheterization Labs
4.5. North America Peripheral Drug Eluting Balloons Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 4.5.1. Key Highlights
  - 4.5.1.1. U.S. Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 4.5.1.2. U.S. Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 4.5.1.3. U.S. Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 4.5.1.4. U.S. Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 4.5.1.5. Canada Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 4.5.1.6. Canada Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 4.5.1.7. Canada Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 4.5.1.8. Canada Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Peripheral Drug Eluting Balloons Market Outlook, 2018 - 2031

5.1. Europe Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Paclitaxel Drug Coating
  - 5.1.1.2. Sirolimus Drug Coating
  - 5.1.1.3. Others
5.2. Europe Peripheral Drug Eluting Balloons Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Peripheral Arterial Disease
  - 5.2.1.2. Peripheral Aneurysms
  - 5.2.1.3. In Stent Restenosis
  - 5.2.1.4. Others
5.3. Europe Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Carotid Arteries
  - 5.3.1.2. Fem-Pop Arteries
  - 5.3.1.3. Illiac Arteries
  - 5.3.1.4. Infrapop Arteries
5.4. Europe Peripheral Drug Eluting Balloons Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Hospitals
  - 5.4.1.2. Ambulatory Surgical Centers / Outpatients
  - 5.4.1.3. Cardiac Catheterization Labs
5.5. Europe Peripheral Drug Eluting Balloons Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Germany Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.2. Germany Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.3. Germany Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.4. Germany Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.5. U.K. Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.6. U.K. Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.7. U.K. Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.8. U.K. Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.9. France Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.10. France Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.11. France Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.12. France Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.13. Italy Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.14. Italy Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.15. Italy Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.16. Italy Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.17. Turkey Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.18. Turkey Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.19. Turkey Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.20. Turkey Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.21. Russia Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.22. Russia Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.23. Russia Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.24. Russia Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.25. Rest of Europe Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.26. Rest of Europe Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.27. Rest of Europe Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.28. Rest of Europe Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Peripheral Drug Eluting Balloons Market Outlook, 2018 - 2031

6.1. Asia Pacific Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Paclitaxel Drug Coating
  - 6.1.1.2. Sirolimus Drug Coating
  - 6.1.1.3. Others
6.2. Asia Pacific Peripheral Drug Eluting Balloons Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Peripheral Arterial Disease
  - 6.2.1.2. Peripheral Aneurysms
  - 6.2.1.3. In Stent Restenosis
  - 6.2.1.4. Others
6.3. Asia Pacific Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Carotid Arteries
  - 6.3.1.2. Fem-Pop Arteries
  - 6.3.1.3. Illiac Arteries
  - 6.3.1.4. Infrapop Arteries
6.4. Asia Pacific Peripheral Drug Eluting Balloons Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Hospitals
  - 6.4.1.2. Ambulatory Surgical Centers / Outpatients
  - 6.4.1.3. Cardiac Catheterization Labs
6.5. Asia Pacific Peripheral Drug Eluting Balloons Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 6.5.1. Key Highlights
  - 6.5.1.1. China Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.2. China Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.3. China Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.4. China Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.5. Japan Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.6. Japan Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.7. Japan Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.8. Japan Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.9. South Korea Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.10. South Korea Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.11. South Korea Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.12. South Korea Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.13. India Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.14. India Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.15. India Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.16. India Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.17. Southeast Asia Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.18. Southeast Asia Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.19. Southeast Asia Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.20. Southeast Asia Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.21. Rest of Asia Pacific Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.22. Rest of Asia Pacific Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.23. Rest of Asia Pacific Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.24. Rest of Asia Pacific Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Peripheral Drug Eluting Balloons Market Outlook, 2018 - 2031

7.1. Latin America Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Paclitaxel Drug Coating
  - 7.1.1.2. Sirolimus Drug Coating
  - 7.1.1.3. Others
7.2. Latin America Peripheral Drug Eluting Balloons Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.3. Latin America Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Carotid Arteries
  - 7.3.1.2. Fem-Pop Arteries
  - 7.3.1.3. Illiac Arteries
  - 7.3.1.4. Infrapop Arteries
7.4. Latin America Peripheral Drug Eluting Balloons Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Hospitals
  - 7.4.1.2. Ambulatory Surgical Centers / Outpatients
  - 7.4.1.3. Cardiac Catheterization Labs
7.5. Latin America Peripheral Drug Eluting Balloons Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Brazil Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.2. Brazil Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.3. Brazil Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.4. Brazil Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.5. Mexico Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.6. Mexico Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.7. Mexico Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.8. Mexico Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.9. Argentina Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.10. Argentina Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.11. Argentina Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.12. Argentina Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.13. Rest of Latin America Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.14. Rest of Latin America Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.15. Rest of Latin America Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.16. Rest of Latin America Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook, 2018 - 2031

8.1. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Paclitaxel Drug Coating
  - 8.1.1.2. Sirolimus Drug Coating
  - 8.1.1.3. Others
8.2. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Peripheral Arterial Disease
  - 8.2.1.2. Peripheral Aneurysms
  - 8.2.1.3. In Stent Restenosis
  - 8.2.1.4. Others
8.3. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Carotid Arteries
  - 8.3.1.2. Fem-Pop Arteries
  - 8.3.1.3. Illiac Arteries
  - 8.3.1.4. Infrapop Arteries
8.4. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Hospitals
  - 8.4.1.2. Ambulatory Surgical Centers / Outpatients
  - 8.4.1.3. Cardiac Catheterization Labs
8.5. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 8.5.1. Key Highlights
  - 8.5.1.1. GCC Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.2. GCC Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.3. GCC Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.4. GCC Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.5. South Africa Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.6. South Africa Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.7. South Africa Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.8. South Africa Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.9. Egypt Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.10. Egypt Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.11. Egypt Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.12. Egypt Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.13. Nigeria Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.14. Nigeria Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.15. Nigeria Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.16. Nigeria Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.17. Rest of Middle East & Africa Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.18. Rest of Middle East & Africa Peripheral Drug Eluting Balloons Market Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.19. Rest of Middle East & Africa Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.20. Rest of Middle East & Africa Peripheral Drug Eluting Balloons Market End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Artery Type vs Indication Heatmap
9.2. Manufacturer vs Indication Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Abbott Laboratories
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Boston Scientific Corporation
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. Cook Medical Inc.
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Microport Scientific Corporation
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Medtronic Plc.
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. Cardinal Health Inc.
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. B. Braun Melsungen AG
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. BIOTRONIK SE & CO. KG
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. Becton, Dickinson and Company
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development
- 9.5.10. W.L. Gore & Associates Co. Ltd.
  - 9.5.10.1. Company Overview
  - 9.5.10.2. Product Portfolio
  - 9.5.10.3. Financial Overview
  - 9.5.10.4. Business Strategies and Development
- 9.5.11. Getinge AB
  - 9.5.11.1. Company Overview
  - 9.5.11.2. Product Portfolio
  - 9.5.11.3. Financial Overview
  - 9.5.11.4. Business Strategies and Development
- 9.5.12. Terumo Corp
  - 9.5.12.1. Company Overview
  - 9.5.12.2. Product Portfolio
  - 9.5.12.3. Financial Overview
  - 9.5.12.4. Business Strategies and Development
- 9.5.13. iVascular S.L.U
  - 9.5.13.1. Company Overview
  - 9.5.13.2. Product Portfolio
  - 9.5.13.3. Financial Overview
  - 9.5.13.4. Business Strategies and Development
- 9.5.14. Kyoto Medical Planning Co Ltd
  - 9.5.14.1. Company Overview
  - 9.5.14.2. Product Portfolio
  - 9.5.14.3. Financial Overview
  - 9.5.14.4. Business Strategies and Development
- 9.5.15. AMG International GmbH
  - 9.5.15.1. Company Overview
  - 9.5.15.2. Product Portfolio
  - 9.5.15.3. Financial Overview
  - 9.5.15.4. Business Strategies and Development
- 9.5.16. Endocor GmbH
  - 9.5.16.1. Company Overview
  - 9.5.16.2. Product Portfolio
  - 9.5.16.3. Financial Overview
  - 9.5.16.4. Business Strategies and Development
- 9.5.17. Meril Life Sciences Pvt. Ltd.
  - 9.5.17.1. Company Overview
  - 9.5.17.2. Product Portfolio
  - 9.5.17.3. Financial Overview
  - 9.5.17.4. Business Strategies and Development
- 9.5.18. Nano Therapeutics Pvt. Ltd.
  - 9.5.18.1. Company Overview
  - 9.5.18.2. Product Portfolio
  - 9.5.18.3. Financial Overview
  - 9.5.18.4. Business Strategies and Development
- 9.5.19. Koninklijke Philips N.V.
  - 9.5.19.1. Company Overview
  - 9.5.19.2. Product Portfolio
  - 9.5.19.3. Financial Overview
  - 9.5.19.4. Business Strategies and Development
- 9.5.20. Reva Medical
  - 9.5.20.1. Company Overview
  - 9.5.20.2. Product Portfolio
  - 9.5.20.3. Financial Overview
  - 9.5.20.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations